News

The American Association for Cancer Research (AACR) annual meeting, held from 25 to 30 April in Chicago, is a major event dedicated to scientific and translational research in oncology. It highlights advances that turn discoveries into tangible clinical applications for patients. Alongside ASCO and ESMO, it is one of the key international...

The Gustave Roussy Foundation is launching an ambitious programme of chairs of excellence to attract and retain the world’s leading cancer researchers. Three inaugural chairs are already operational under the leadership of internationally renowned scientists. The ambition is to accelerate breakthroughs in the fight against cancer.

On 19 March, the 4th edition of the Transatlantic Exchanges took place in Paris—a scientific day co-organised by Gustave Roussy and the Dana-Farber Cancer Institute with support from the Servier Institute. Dr. Toni Choueiri (Dana-Farber) and Prof. Karim Fizazi (Gustave Roussy), co-chairs of the event, reflect on the key themes of this edition,...

Named Gustave Roussy International Egypt, the opening of a cancer centre in Cairo, Egypt, marks the transformation of the Dar Al-Salam-Hermel Oncology Hospital under a brand licensing agreement with Gustave Roussy International, a subsidiary of Gustave Roussy.

In 2024, the Nuclear Safety and Radiation Protection Authority (ASNR) and the Regional Health Agency (ARS) Île-de-France authorised Gustave Roussy to conduct Phase I trials in nuclear medicine, the first stage in the clinical validation process of a new treatment.

Pragmatic trials are simple, affordable trials aiming to inform or change practice broadly. Prof Alexandra Leary, MD, Ph.D., a medical oncologist at Gustave Roussy and deputy head of the Medical Oncology Department, explains these trials in five questions.

Gustave Roussy and the Dana-Farber Cancer Institute (Boston, United States) are organising the fourth edition of the Transatlantic Exchange oncology conference on 19 March 2025 at the Hyatt Regency Paris Étoile hotel. The theme will be “Radiopharmaceutical Therapy Meets Oncology.”

Unveiled on World Cancer Day, February 4, 2025, Gustave Roussy’s latest campaign delivers a powerful message of hope and scientific progress.

The laying of the foundation stone marks a decisive milestone in developing the Paris-Saclay Cancer Cluster, which is currently being established around Gustave Roussy and is set to become the largest oncology hub in Europe.

A medical oncologist at Gustave Roussy and director of the personalised prevention program Interception, Dr. Suzette Delaloge has been honoured by the Ruban Rose Association for her research aimed at developing a saliva test capable of detecting early signs of breast cancer.